These results suggest that the switch in the direction of correlation between CLDN1 and CD44 in matched primary—recurrent tumors plays an important biological role in tumor recurrence, as does the strengthened and significant positive correlation between CD44 and CLDN4 and CLDN7 that is only apparent in recurrent disease. The gene discussed is CLDN1; the disease is neoplasm.